P
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$69.2m
FY2015FY2025
Net income
$4.6m
FY2015FY2025
Free cash flow
$12.9m
FY2015FY2025
Shareholders' equity
$153.1m
FY2015FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69.2m | $60.2m | $53.5m | $47.3m | $40.8m | $29.9m | $22.9m | $11.6m | $468.9m | $542.0m |
| Research and development | $15.4m | $12.0m | $11.5m | $10.5m | $9.8m | $7.6m | $6.1m | $5.9m | — | — |
| Operating income | $265,000 | −$3.1m | −$5.7m | −$71.1m | −$5.0m | −$2.8m | −$1.4m | −$9.0m | −$16.7m | −$4.0m |
| Net income | $4.6m | $5.0m | $5.4m | −$161.7m | −$156.9m | −$5.6m | −$2.0m | −$8.7m | −$23.6m | −$11.7m |
| Diluted earnings per share | 0.05 | 0.05 | 0.05 | -1.37 | -1.33 | -0.05 | -0.02 | -0.07 | -0.19 | -0.09 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $192.0m | $181.2m | $170.4m | $210.3m | $88.9m | $86.2m | $44.5m | — | $310.3m | $351.0m |
| Cash and short-term investments | $162.3m | $165.9m | $154.2m | $192.6m | $80.5m | $79.0m | $36.1m | — | $7.5m | $5.6m |
| Total liabilities | $38.9m | $34.2m | $31.0m | $28.3m | $279.3m | $122.0m | $65.7m | — | $249.9m | $267.1m |
| Debt | $444,000 | $2.3m | $2.4m | $3.5m | $259.9m | $108.8m | $247,000 | — | $1.2m | $1.2m |
| Shareholders' equity | $153.1m | $147.0m | $139.4m | $182.0m | −$190.4m | −$35.7m | −$21.2m | — | $60.4m | $84.0m |
| Shares outstanding | 98m | 110m | 108m | 118m | 118m | 118m | 118m | 118m | 124m | 124m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $13.3m | $13.0m | $13.6m | −$3.3m | −$1.1m | $2.2m | −$1.3m | −$7.8m | $19.3m | $38.1m |
| Capital spending | −$425,000 | −$392,000 | −$289,000 | −$165,000 | −$154,000 | −$292,000 | −$236,000 | −$123,000 | −$3.1m | −$8.5m |
| Free cash flow | $12.9m | $12.6m | $13.3m | −$3.5m | −$1.3m | $1.9m | −$1.5m | −$7.9m | $16.1m | $29.6m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.3m | $17.9m | $18.1m | $18.7m | $16.3m | $16.0m | $15.9m | $16.1m |
| Operating income | −$108,000 | $1.5m | $1.4m | $497,000 | −$1.5m | −$157,000 | −$481,000 | −$77,000 |
| Net income | $1.3m | $2.4m | $63,000 | $2.1m | $207,000 | $2.3m | $1.1m | $2.5m |
| Diluted earnings per share | 0.01 | 0.02 | 0.00 | 0.02 | 0.00 | 0.02 | 0.01 | 0.02 |
| Cash from operations | — | $4.0m | $2.0m | $2.0m | $3.0m | $4.0m | $3.0m | $4.0m |
| Total assets | $194.6m | $194.9m | $192.0m | $194.2m | $190.2m | $187.3m | $181.2m | $179.6m |
| Cash and short-term investments | $162.0m | $161.3m | $162.3m | $170.1m | $167.8m | $164.6m | $165.9m | $163.2m |
| Debt | $478,000 | $400,000 | $444,000 | $458,000 | $460,000 | $307,000 | $402,000 | $484,000 |
| Shareholders' equity | $156.9m | $155.6m | $153.1m | $152.9m | $150.6m | $150.0m | $147.0m | $145.5m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 13.5% | 18.3% | -19.2% |
| Operating income | — | — | -32.0% |
| Net income | — | — | 5.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -2.2% | -34.6% | -29.1% | -5.5% |
| Net margin | 7.5% | -63.7% | -102.8% | -18.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 38.0 | 61.7 | 62.0 | -5.2 |
| Price to sales | 2.5 | 5.2 | 6.3 | 17.9 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Return | -17% | -29% | -57% | 5% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.